参考文献/References:
[1]Liu Y,Shete S,Etzel CJ,et al.Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival[J].J Clin Oncol,2010,28(14):2467-2474.[2]Zikou A,Sioka C,Alexiou GA,et al.Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas[J].Contrast Media Mol Imaging,2018,2018:6828396.[3]Alexiou GA,Tsiouris S,Kyritsis AP,et al.Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities[J].J Neurooncol,2009,95(1):1-11.[4]Galldiks N,Kocher M,Langen KJ.Pseudoprogression after glioma therapy: an update[J].Expert Rev Neurother,2017,17(11):1109-1115.[5]Giglio P,Gilbert MR.Cerebral radiation necrosis[J].Neurologist,2003,9(4):180-188.[6]Thust SC,van den Bent MJ,Smits M.Pseudoprogression of brain tumors[J].J Magn Reson Imaging,2018,48(3):571-589.[7]Brandsma D,Stalpers L,Taal W,et al.Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas[J].Lancet Oncol,2008,9(5):453-461.[8]Taal W,Brandsma D,de Bruin HG,et al.Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide[J].Cancer,2008,113(2):405-410.[9]Brandes AA,Tosoni A,Spagnolli F,et al.Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology[J].Neuro Oncol,2008,10(3):361-367.[10]Hegi ME,Diserens AC,Gorlia T,et al.MGMT gene silencing and benefit from temozolomide in glioblastoma[J].N Engl J Med,2005,352(10):997-1003.[11]Franceschi E,Tosoni A,Pozzati E,et al.Association between response to primary treatments and MGMT status in glioblastoma[J].Expert Rev Anticancer Ther,2008,8(11):1781-1786.[12]Hygino da Cruz LC Jr,Rodriguez I,Domingues RC,et al.Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma[J].AJNR Am J Neuroradiol,2011,32(11):1978-1985.[13]Macdonald DR,Cascino TL,Schold SC Jr,et al.Response criteria for phase Ⅱ studies of supratentorial malignant glioma[J].J Clin Oncol,1990,8(7):1277-1280.[14]Delgado-López PD,Ri?觡ones-Mena E,Corrales-García EM.Treatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosis[J].Clin Transl Oncol,2018,20(8):939-953.[15]Zhang H,Ma L,Shu C,et al.Diagnostic accuracy of diffusion MRI with quantitative ADC measurements in differentiating glioma recurrence from radiation necrosis[J].J Neurol Sci,2015,351(1-2):65-71.[16]刘静静,黄雪莹,党佩,等.体素内不相干运动成像对脑胶质瘤术后复发与假性进展的鉴别诊断[J].中国医学影像学杂志,2022,30(1):17-22.[17]Liu ZC,Yan LF,Hu YC,et al.Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial[J].BMC Med Imaging,2017,17(1):10.[18]王斌,张辉,王效春,等.体素内不相干运动成像监测脑胶质瘤复发和治疗后反应的初步探讨[J].中西医结合心脑血管病杂志,2017,15(17):2202-2204.[19]Al Sayyari A,Buckley R,McHenery C,et al.Distinguishing recurrent primary brain tumor from radiation injury: a preliminary study using a susceptibility-weighted MR imaging-guided apparent diffusion coefficient analysis strategy[J].AJNR Am J Neuroradiol,2010,31(6):1049-1054.[20]Perez-Torres CJ,Engelbach JA,Cates J,et al.Toward distinguishing recurrent tumor from radiation necrosis: DWI and MTC in a Gamma Knife--irradiated mouse glioma model[J].Int J Radiat Oncol Biol Phys,2014,90(2):446-453.[21]Cao M,Suo S,Han X,et al.Application of a Simplified Method for Estimating Perfusion Derived from Diffusion-Weighted MR Imaging in Glioma Grading[J].Front Aging Neurosci,2018,9:432.[22]徐曼,余永强,侯唯姝,等.体素内不相干运动DWI评估SD大鼠C6脑胶质瘤模型肿瘤微环境乏氧状态[J].中国医学影像技术,2019,35(2):170-174.[23]党佩,王立东,黄雪莹,等.DKI在鉴别脑胶质瘤复发与假性进展中的应用价值研究[J].磁共振成像,2022,13(5):28-33.[24]Thomas AA,Arevalo-Perez J,Kaley T,et al.Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma[J].J Neurooncol,2015,125(1):183-190.[25]Yoo RE,Choi SH,Kim TM,et al.Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study[J].Eur Radiol,2017,27(8):3156-3166.[26]Prager AJ,Martinez N,Beal K,et al.Diffusion and perfusion MRI to differentiate treatment-related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence[J].AJNR Am J Neuroradiol,2015,36(5):877-885.[27]Wang S,Martinez-Lage M,Sakai Y,et al.Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI[J].AJNR Am J Neuroradiol,2016,37(1):28-36.[28]潘锋,吴晓,苏中周,等.3D-ASL技术联合DWI在鉴别脑胶质瘤术后复发与假性进展中的应用价值[J].临床放射学杂志,2018,37(6):904-908.[29]申小明,张仙海,洪居陆,等.ASL和MRS技术对高级别胶质瘤术后复发和假性进展鉴别诊断的价值[J].现代医用影像学,2021,30(11):2014-2017.[30]胡丽霞,朱进,唐娜,等.磁共振ASL技术在鉴别高级别脑胶质瘤治疗后假性进展中的应用[J].中国CT和MRI杂志,2019,17(8):4-7,35.[31]Zeng QS,Li CF,Zhang K,et al.Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury[J].J Neurooncol,2007,84(1):63-69.[32]王季华,张在云,李晓梅,等.MRS联合ASL在高级别脑胶质瘤假性进展诊断中的应用[J].医学影像学杂志,2016,26(7):1153-1156.[33]李万湖,胡旭东,徐亮,等.胶质瘤治疗后假性进展的MR波谱分析[J].中国辐射卫生,2014,23(2):112-114.[34]Elias AE,Carlos RC,Smith EA,et al.MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury[J].Acad Radiol,2011,18(9):1101-1108.[35]Lichy MP,Bachert P,Henze M,et al.Monitoring individual response to brain-tumour chemotherapy: proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy[J].Neuroradiology,2004,46(2):126-129.[36]Ando K,Ishikura R,Nagami Y,et al.[Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions][J].Nihon Igaku Hoshasen Gakkai Zasshi,2004;64(3):121-126.[37]李丽,王振雄,方纪成,等.化学交换饱和转移衍生新技术的开发与临床应用[J].放射学实践,2020,35(1):2-8.[38]Park KJ,Kim HS,Park JE,et al.Added value of amide proton transfer imaging to conventional and perfusion MR imaging for evaluating the treatment response of newly diagnosed glioblastoma[J].Eur Radiol,2016,26(12):4390-4403.[39]Park JE,Kim HS,Park KJ,et al.Pre- and Posttreatment Glioma: Comparison of Amide Proton Transfer Imaging with MR Spectroscopy for Biomarkers of Tumor Proliferation[J].Radiology,2016,278(2):514-523.[40]Ma B,Blakeley JO,Hong X,et al.Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas[J].J Magn Reson Imaging,2016,44(2):456-462.[41]Park JE,Ham S,Kim HS,et al.Diffusion and perfusion MRI radiomics obtained from deep learning segmentation provides reproducible and comparable diagnostic model to human in post-treatment glioblastoma[J].Eur Radiol,2021,31(5):3127-3137.[42]Kim JY,Park JE,Jo Y,et al.Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients[J].Neuro Oncol,2019,21(3):404-414.[43]Elshafeey N,Kotrotsou A,Hassan A,et al.Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma[J].Nat Commun,2019,10(1):3170.
相似文献/References:
[1]王春城.三维适形放疗在脑胶质瘤治疗中的应用及对生存期的影响[J].医学信息,2019,32(05):173.[doi:10.3969/j.issn.1006-1959.2019.05.057]
WANG Chun-cheng.Application of Three-dimensional Conformal Radiotherapy in the Treatment of Glioma and its Effect on Survival[J].Journal of Medical Information,2019,32(14):173.[doi:10.3969/j.issn.1006-1959.2019.05.057]
[2]贾 丁,王春红,杨孝燕,等.程序性死亡因子1及其配体在脑胶质瘤中的研究进展[J].医学信息,2019,32(10):47.[doi:10.3969/j.issn.1006-1959.2019.10.017]
JIA Ding,WANG Chun-hong,YANG Xiao-yan,et al.Progress in the Study of Programmed Death Factor 1 and its Ligands in Glioma[J].Journal of Medical Information,2019,32(14):47.[doi:10.3969/j.issn.1006-1959.2019.10.017]
[3]黄梦倩,张瑞恒,刘楚浩,等.影像组学在神经系统疾病中的应用研究[J].医学信息,2019,32(16):47.[doi:10.3969/j.issn.1006-1959.2019.16.015]
HUANG Meng-qian,ZHANG Rui-heng,LIU Chu-hao,et al.Application of Radiomics in Nervous System Diseases[J].Journal of Medical Information,2019,32(14):47.[doi:10.3969/j.issn.1006-1959.2019.16.015]
[4]杨婷婷,占 鸣,谢春梅,等.T2WI灰度直方图定量分析在原发性中枢神经系统淋巴瘤和脑胶质瘤鉴别诊断中的价值[J].医学信息,2021,34(13):4.[doi:10.3969/j.issn.1006-1959.2021.13.002]
YANG Ting-ting,ZHAN Ming,XIE Chun-mei,et al.Quantitative Analysis of T2WI Gray Histogram in the Differential Diagnosis of Primary Central Nervous System Lymphoma and Glioma[J].Journal of Medical Information,2021,34(14):4.[doi:10.3969/j.issn.1006-1959.2021.13.002]
[5]王国杰,梁日晶,刘 莹,等.3.0T磁共振扩散张量成像与扩散加权成像对单发大脑半球胶质瘤病理分级的诊断价值[J].医学信息,2022,35(09):104.[doi:10.3969/j.issn.1006-1959.2022.09.026]
WANG Guo-jie,LIANG Ri-jing,LIU Ying,et al.Diagnostic Value of 3.0T Magnetic Resonance Diffusion Tensor Imaging and Diffusion Weighted Imaging in Pathological Grading of Single Cerebral Hemispheric Glioma[J].Journal of Medical Information,2022,35(14):104.[doi:10.3969/j.issn.1006-1959.2022.09.026]
[6]蒙新宇.显微镜外科手术治疗脑胶质瘤的近期疗效及对患者认知功能的影响[J].医学信息,2022,35(12):146.[doi:10.3969/j.issn.1006-1959.2022.12.035]
MENG Xin-yu.Effect of Microsurgery on Cognitive Function in Patients with Brain Glioma[J].Journal of Medical Information,2022,35(14):146.[doi:10.3969/j.issn.1006-1959.2022.12.035]
[7]乔秋江,庞 琦.基于自噬相关基因构建的预后模型对脑胶质瘤免疫微环境的影响[J].医学信息,2022,35(17):1.[doi:10.3969/j.issn.1006-1959.2022.17.001]
QIAO Qiu-jiang,PANG Qi.Effect of Prognostic Model Based on Autophagy-related Genes on Immune Microenvironment of Glioma[J].Journal of Medical Information,2022,35(14):1.[doi:10.3969/j.issn.1006-1959.2022.17.001]
[8]许高权.立体定向微创手术治疗脑胶质瘤的临床效果及对患者神经功能和日常生活能力的影响[J].医学信息,2022,35(17):76.[doi:10.3969/j.issn.1006-1959.2022.17.019]
XU Gao-quan.The Clinical Effect of Stereotactic Minimally Invasive Surgery in the Treatment of Patients with Glioma and its Influence on Nerve Function and Daily Living Ability[J].Journal of Medical Information,2022,35(14):76.[doi:10.3969/j.issn.1006-1959.2022.17.019]
[9]许高权.显微外科手术对脑胶质瘤患者认知功能和远期生存率的影响[J].医学信息,2022,35(22):106.[doi:10.3969/j.issn.1006-1959.2022.22.022]
XU Gao-quan.Effect of Microsurgery on Cognitive Function and Long-term Survival Rate in Patients with Glioma[J].Journal of Medical Information,2022,35(14):106.[doi:10.3969/j.issn.1006-1959.2022.22.022]
[10]张小芬,陆依娜,徐千惠,等.SWI在脑胶质瘤诊断和治疗中的应用进展[J].医学信息,2023,36(06):181.[doi:10.3969/j.issn.1006-1959.2023.06.041]
ZHANG Xiao-fen,LU Yi-na,XU Qian-hui,et al.Application Progress of SWI in Diagnosis and Treatment of Glioma[J].Journal of Medical Information,2023,36(14):181.[doi:10.3969/j.issn.1006-1959.2023.06.041]